Contributors |
|
xi | |
About the authors |
|
xiii | |
Preface |
|
xvii | |
Acknowledgments |
|
xix | |
|
1 Imidazole and its derivatives: Introduction and synthetic aspects |
|
|
|
|
|
|
|
1 | (4) |
|
2 Synthesis of substituted imidazoles |
|
|
5 | (9) |
|
2.1 Mono-substituted imidazole derivatives |
|
|
5 | (1) |
|
2.2 Di-substituted imidazole derivatives |
|
|
6 | (2) |
|
2.3 Tri-substituted imidazole derivatives |
|
|
8 | (4) |
|
2.4 Tetra-substituted imidazole derivatives |
|
|
12 | (2) |
|
|
14 | (6) |
|
3.1 Imidazole fused heterocycles |
|
|
15 | (3) |
|
3.2 Benzimidazole fused heterocycles |
|
|
18 | (2) |
|
|
20 | (3) |
|
|
21 | (1) |
|
4.2 Synthesis of benzimidazoles using o-phenylene diamine and acids |
|
|
21 | (1) |
|
4.3 Synthesis of benzimidazoles using o-phenylene diamine and acid anhydride |
|
|
21 | (1) |
|
4.4 Synthesis of benzimidazoles using o-phenylene diamine and alcohols |
|
|
21 | (1) |
|
4.5 Synthesis of benzimidazoles using o-phenylene diamine and alkyl halides |
|
|
22 | (1) |
|
4.6 Synthesis of benzimidazoles using ketones |
|
|
22 | (1) |
|
4.7 Synthesis of benzimidazoles using o-phenylene diamine and aldehydes |
|
|
23 | (1) |
|
|
23 | (13) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
25 | (11) |
|
2 Biological profile of imidazole-based compounds as anticancer agents |
|
|
|
|
|
|
|
|
|
|
36 | (2) |
|
2 Imidazole-based heterocycles |
|
|
38 | (84) |
|
2.1 Imidazole as the main nucleus in the anticancer compounds |
|
|
39 | (29) |
|
2.2 Imidazole hybrids as anticancer agents |
|
|
68 | (20) |
|
2.3 Imidazole fused heterocycles |
|
|
88 | (24) |
|
2.4 Imidazole-based metal complexes as anticancer agents |
|
|
112 | (10) |
|
3 Conclusion and future challenges |
|
|
122 | (12) |
|
|
122 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
123 | (11) |
|
3 Recent advancements on imidazole containing heterocycles as antitubercular agents |
|
|
|
|
|
|
|
|
|
|
134 | (1) |
|
2 Imidazole-based heterocycles |
|
|
135 | (26) |
|
2.1 Substituted imidazoles |
|
|
135 | (5) |
|
|
140 | (2) |
|
|
142 | (10) |
|
|
152 | (3) |
|
|
155 | (6) |
|
|
161 | (7) |
|
|
161 | (1) |
|
|
162 | (1) |
|
|
162 | (1) |
|
|
162 | (6) |
|
4 Imidazole derivatives: Impact and prospects in antiviral drug discovery |
|
|
|
|
|
|
|
|
|
168 | (2) |
|
2 Imidazole derivatives and their action against different viruses |
|
|
170 | (17) |
|
|
170 | (2) |
|
|
172 | (3) |
|
|
175 | (2) |
|
|
177 | (1) |
|
|
178 | (3) |
|
|
181 | (2) |
|
|
183 | (4) |
|
|
187 | (8) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
188 | (7) |
|
5 Imidazole heterocycles: Therapeutically potent lead compounds as antimicrobials |
|
|
|
|
|
|
|
195 | (2) |
|
2 Imidazole-based antimicrobial compounds |
|
|
197 | (52) |
|
2.1 Based on imidazole ring generation |
|
|
197 | (26) |
|
2.2 Based on linked moieties |
|
|
223 | (15) |
|
2.3 Based on metal complex |
|
|
238 | (8) |
|
2.4 Based on imidazolium salt or ionic liquids |
|
|
246 | (2) |
|
|
248 | (1) |
|
3 Conclusion and future perspectives |
|
|
249 | (14) |
|
|
250 | (1) |
|
|
250 | (1) |
|
|
250 | (1) |
|
|
250 | (13) |
|
6 Imidazole containing heterocycles as antioxidants |
|
|
|
|
|
|
|
|
263 | (1) |
|
2 Imidazole-based antioxidant compounds |
|
|
264 | (21) |
|
|
265 | (13) |
|
|
278 | (7) |
|
3 Conclusion and future perspectives |
|
|
285 | (6) |
|
|
285 | (1) |
|
|
286 | (1) |
|
|
286 | (1) |
|
|
286 | (5) |
|
7 Miscellaneous biological activity profile of imidazole-based compounds: An aspirational goal for medicinal chemistry |
|
|
|
|
|
|
|
|
291 | (2) |
|
2 Imidazole-based bioactive compounds |
|
|
293 | (22) |
|
2.1 Antiparasitic activity |
|
|
293 | (7) |
|
2.2 Anti-Alzheimer's activity |
|
|
300 | (4) |
|
2.3 Antiinflammatory activity |
|
|
304 | (2) |
|
2.4 Antidiabetic activity |
|
|
306 | (2) |
|
2.5 Antihypertensive activity |
|
|
308 | (2) |
|
2.6 Antidepressant activity |
|
|
310 | (1) |
|
2.7 Miscellaneous activities |
|
|
310 | (5) |
|
3 Conclusion and future perspectives |
|
|
315 | (8) |
|
|
316 | (1) |
|
|
316 | (1) |
|
|
316 | (1) |
|
|
316 | (7) |
|
8 Imidazole-based drugs and drug discovery: Present and future perspectives |
|
|
|
|
|
|
|
|
323 | (1) |
|
2 Imidazole-based market available drugs |
|
|
324 | (6) |
|
3 Pharmacokinetics and pharmacodynamic profiles of a drug |
|
|
330 | (1) |
|
4 Synergy between imidazole-based compounds and drug development |
|
|
330 | (13) |
|
4.1 Rational approaches to find imidazole-based drugs |
|
|
330 | (2) |
|
4.2 Imidazole hybrids as a hit for several diseases |
|
|
332 | (2) |
|
4.3 Clinical trials on imidazole-based compounds |
|
|
334 | (1) |
|
4.4 Patents on imidazole-based compounds |
|
|
334 | (9) |
|
5 Conclusion and future prospects |
|
|
343 | (6) |
|
|
344 | (1) |
|
|
344 | (1) |
|
|
344 | (1) |
|
|
344 | (4) |
|
|
348 | (1) |
Index |
|
349 | |